<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gastro-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Gastroenterology, Hepatology, Coloproctology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1382-4376</issn><issn pub-type="epub">2658-6673</issn><publisher><publisher-name>«Gastro» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22416/1382-4376-2024-34-1-7-14</article-id><article-id custom-type="elpub" pub-id-type="custom">gastro-j-758</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Патогенез функциональной билиарной боли и фармакология тримебутина</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenesis of Functional Biliary Pain and Pharmacology of Trimebutin</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0700-9775</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буеверова</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Bueverova</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буеверова Елена Леонидовна — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии </p><p>119435, г. Москва, ул. Погодинская, 1, стр. 1</p></bio><bio xml:lang="en"><p>Elena L. Bueverova — Cand. Sci.  (Med.),  Associate Professor at the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology</p><p>119435, Moscow, Pogodinskaya str., 1, build. 1</p></bio><email xlink:type="simple">bueverova_e_l@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6701-789X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зольникова</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Zolnikova</surname><given-names>O. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зольникова Оксана Юрьевна — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии </p><p>119435, г. Москва, ул. Погодинская, 1, стр. 1</p></bio><bio xml:lang="en"><p>Oxana   Yu.   Zolnikova   —   Dr.   Sci.   (Med.), Professor   at the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology</p><p>119435, Moscow, Pogodinskaya str., 1, build. 1</p></bio><email xlink:type="simple">zolnikova_o_yu@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5081-3390</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джахая</surname><given-names>Н. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhakhaya</surname><given-names>N. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джахая Натия Леонтьевна — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии </p><p>119435, г. Москва, ул. Погодинская, 1, стр. 1</p></bio><bio xml:lang="en"><p>Natiya L. Dzhakhaya — Cand. Sci. (Med.), Associate Professor at the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology</p><p>119435, Moscow, Pogodinskaya str., 1, build. 1</p></bio><email xlink:type="simple">dzhakhaya_n_l@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1644-264X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Седова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sedova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Седова Алла Владимировна — кандидат медицинских наук, ассистент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии </p><p>119435, г. Москва, ул. Погодинская, 1, стр. 1</p></bio><bio xml:lang="en"><p>Alla V. Sedova — Cand. Sci. (Med.), Teaching Assistant at the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology</p><p>119435, Moscow, Pogodinskaya str., 1, build. 1</p></bio><email xlink:type="simple">sedova_a_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6815-6015</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ивашкин</surname><given-names>В. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivashkin</surname><given-names>V. Т.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ивашкин Владимир Трофимович — доктор медицинских наук, профессор, академик РАН, заведующий кафедрой пропедевтики внутренних болезней, гастроэнтерологии и гепатологии </p><p>119435, г. Москва, ул. Погодинская, 1, стр. 1</p></bio><bio xml:lang="en"><p>Vladimir Т. Ivashkin — Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head of the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology</p><p>119435, Moscow, Pogodinskaya str., 1, build. 1</p></bio><email xlink:type="simple">ivashkin_v_t@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>02</month><year>2024</year></pub-date><volume>34</volume><issue>1</issue><fpage>7</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Буеверова Е.Л., Зольникова О.Ю., Джахая Н.Л., Седова А.В., Ивашкин В.Т., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Буеверова Е.Л., Зольникова О.Ю., Джахая Н.Л., Седова А.В., Ивашкин В.Т.</copyright-holder><copyright-holder xml:lang="en">Bueverova E.L., Zolnikova O.Y., Dzhakhaya N.L., Sedova A.V., Ivashkin V.Т.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gastro-j.ru/jour/article/view/758">https://www.gastro-j.ru/jour/article/view/758</self-uri><abstract><sec><title>Цель</title><p>Цель: представить данные о патогенезе функциональной билиарной боли и дать обоснование применения тримебутина по данному показанию.</p></sec><sec><title>Основные положения</title><p>Основные положения. Билиарная боль служит одним из самых частых поводов обращения пациентов к врачу. Диагноз функционального расстройства желчного пузыря и сфинктера Одди правомерен только после исключения органических причин со стороны как желудочно-кишечного тракта, так и других органов и систем. Первичное обращение к хирургам с жалобой на боль в эпигастрии или правом подреберье может привести к необоснованному хирургическому вмешательству, не приносящему облегчения страданиям пациента. Последствия холецистэктомии также создают анатомо-физиологическое обоснование возникновения или сохранения билиарной боли. В настоящее время рассматриваются две основные гипотезы, объясняющие ее причину: повышение внутрипросветного давления из-за морфологических и функциональных препятствий оттоку желчи и висцеральная гиперчувствительность. В многоуровневой системе регуляции работы желчного пузыря и сфинктерного аппарата особое место занимает энкефалинергическая система. Агонист периферических рецепторов энкефалинергической системы тримебутин в клинических исследованиях приводил к купированию билиарной боли более чем у 80 % пациентов с функциональными билиарными расстройствами; одновременно выявлено достоверное уменьшение выраженности диарейного, диспепсического, констипационного синдромов.</p></sec><sec><title>Заключение</title><p>Заключение. Назначение агониста периферических рецепторов энкефалинергической системы тримебутина патогенетически обосновано при функциональной билиарной боли.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim: to provide data on the pathogenesis of functional biliary pain and provide rationale for the use of trimebutine for this indication.</p></sec><sec><title>Key points</title><p>Key points. Biliary pain is one of the most frequent reasons for patients to see a doctor. The diagnosis of functional disorder of the gallbladder and Oddi's sphincter is legitimate only after the exclusion of organic causes from both the gastrointestinal tract and other organs and systems. The initial appeal to surgeons with a complaint of pain in the epigastrium or right hypochondrium may lead to unjustified surgical intervention that does not bring relief to the patient's suffering. The consequences of cholecystectomy also have an anatomical and physiological justification for the occurrence or preservation of biliary pain. Currently, two main hypotheses are being considered to explain its cause: increased intraluminal pressure due to morphological and functional obstacles to bile outflow and visceral hypersensitivity. In the multilevel system of regulation of the gallbladder and sphincter apparatus, the opioid system occupies a special place. The agonist of peripheral receptors of the enkephalinergic system, trimebutine, in clinical studies led to the relief of biliary pain in more than 80 % of patients with functional biliary disorders, while a significant decrease in the severity of diarrhea, dyspeptic, and constipation syndromes was revealed.</p></sec><sec><title>Conclusion</title><p>Conclusion. The prescription of the peripheral receptor agonist of the enkephalinergic system, trimebutine, is pathogenetically justified for functional biliary pain.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>функциональные расстройства</kwd><kwd>билиарная боль</kwd><kwd>патогенез</kwd><kwd>тримебутин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>functional disorders</kwd><kwd>biliary pain</kwd><kwd>pathogenesis</kwd><kwd>trimebutine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Маев И.В., Шульпекова Ю.О., Баранская Е.К., Охлобыстин А.В., Трухманов А.С. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению дискинезии желчевыводящих путей. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(3):63–80. DOI: 10.22416/1382-4376-2018-28-3-63-80</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Mayev I.V., Shulpekova Yu.O., Baranskaya E.K., Okhlobystin A.V., Trukhmanov A.S., et al. Diagnostics and treatment of biliary dyskinesia: Clinical guidelines of the Russian gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(3):63–80. (In Russ.). DOI: 10.22416/1382-4376-2018-28-3-63-80</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cotton P.B., Elta G.H., Carter C.R., Pasricha P.J., Corazziari E.S. Rome IV. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;S0016– 5085(16)00224-9. (Online ahead of print). DOI: 10.1053/j.gastro.2016.02.033</mixed-citation><mixed-citation xml:lang="en">Cotton P.B., Elta G.H., Carter C.R., Pasricha P.J., Corazziari E.S. Rome IV. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;S0016– 5085(16)00224-9. (Online ahead of print). DOI: 10.1053/j.gastro.2016.02.033</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rose J., Fields R., Strasberg S. Poor reproducibility of gallbladder ejection fraction by biliary scintigraphy for diagnosis of biliary dyskinesia. J Am Coll Surg. 2018;226(2):155–9. DOI: 10.1016/j.jamcollsurg.2017.10.025</mixed-citation><mixed-citation xml:lang="en">Rose J., Fields R., Strasberg S. Poor reproducibility of gallbladder ejection fraction by biliary scintigraphy for diagnosis of biliary dyskinesia. J Am Coll Surg. 2018;226(2):155–9. DOI: 10.1016/j.jamcollsurg.2017.10.025</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Осипенко М.Ф., Бут-Гусаим В.И., Волошина Н.Б., Бикбулатова Е.А. Синдром «перекреста»: синдром раздраженного кишечника и функциональные расстройства билиарного тракта. Сибирский медицинский журнал. 2008;80(5):21–6.</mixed-citation><mixed-citation xml:lang="en">Osipenko M.F., But-Gusaim V.I., Voloshina N.B., Bicbulatova E.A. “Overlap syndrome” irritable bowel syndrome and functional gallbladder and sphincter of Oddi disorders. Baikal Medical Journal. 2008;80(5):21–6. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Latenstein C.S.S., Wennmacker S.Z., de Jong J.J., van Laarhoven C.J.H.M., Drenth J.P.H., de Reuver P.R. Etiologies of long-term postcholecystectomy symptoms: A systematic review. Gastroenterol Res Pract. 2019;2019:4278373. DOI: 10.1155/2019/4278373</mixed-citation><mixed-citation xml:lang="en">Latenstein C.S.S., Wennmacker S.Z., de Jong J.J., van Laarhoven C.J.H.M., Drenth J.P.H., de Reuver P.R. Etiologies of long-term postcholecystectomy symptoms: A systematic review. Gastroenterol Res Pract. 2019;2019:4278373. DOI: 10.1155/2019/4278373</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Шульпекова Ю.О., Нечаев В.М., Ивашкин В.Т. Билиарная боль в структуре случаев боли в правом подреберье. Вопросы детской диетологии. 2020;18(6):42– 52. DOI: 10.20953/1727-5784-2020-6-42-52</mixed-citation><mixed-citation xml:lang="en">Shulpekova Yu.O., Nechaev V.M., Ivashkin V.T. Biliary pain in the structure of episodes of right upper abdominal pain. Pediatric Nutrition. 2020;18(6):42–52. (In Russ.). DOI: 10.20953/1727-5784-2020-6-42-52</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Drossman D.A. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262–79.e2. DOI: 10.1053/j.gastro.2016.02.032</mixed-citation><mixed-citation xml:lang="en">Drossman D.A. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262–79.e2. DOI: 10.1053/j.gastro.2016.02.032</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Шептулин А.А., Кардашева С.С. Спорные вопросы функциональных расстройств желчного пузыря и сфинктера Одди: анализ Римских критериев IV пересмотра (2016 г.). Клиническая медицина. 2018;96(1):84–7. DOI: 10.18821/0023-2149-2018-96-1-84-87</mixed-citation><mixed-citation xml:lang="en">Sheptulin A.A., Kardasheva S.S. Controversial issues of gallbladder and sphincter Oddi disorders: Analysis of Rome IV criteria (2016). Clinical Medicine. Russian Journal. 2018;96(1):84–7. (In Russ.). DOI: 10.18821/0023-2149-2018-96-1-84-87</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lavoie B., Nausch B., Zane E.A., Leonard M.R., Balemba O.B., Bartoo A.C., et al. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil. 2012;24(7):e313–24. DOI: 10.1111/j.1365-2982.2012.01935.x</mixed-citation><mixed-citation xml:lang="en">Lavoie B., Nausch B., Zane E.A., Leonard M.R., Balemba O.B., Bartoo A.C., et al. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil. 2012;24(7):e313–24. DOI: 10.1111/j.1365-2982.2012.01935.x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Свистунов А.А., Буторова Л.И., Осадчук М.А., Киреева Н.В., Токмулина Г.М., Ардатская М.Д. Синдром билиарной боли в свете Римских критериев IV: рациональный подход к выбору спазмолитической терапии в клинической практике. Доказательная гастроэнтерология. 2018;7(2):59–69. DOI: 10.17116/dokgastro20187259</mixed-citation><mixed-citation xml:lang="en">Svistunov A.A., Butorova L.I., Osadchuk M.A., Kireeva N.V., Tokmulina G.M., Ardatskaya M.D. The biliary pain syndrome in the context of Rome IV criteria: The rational approach to the choice of spasmolytic therapy in the clinical practice. Russian Journal of Evidence-Based Gastroenterology. 2018;7(2):59– 69. (In Russ.). DOI: 10.17116/dokgastro20187259</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Z.-P., Qiu H., Yu B.-P. Distribution changes of interstitial cells of Cajal during cholesterol gallstone formation in guinea pigs fed a high cholesterol diet. Int J Clin Exp Pathol. 2018;11(3):1653–9.</mixed-citation><mixed-citation xml:lang="en">Huang Z.-P., Qiu H., Yu B.-P. Distribution changes of interstitial cells of Cajal during cholesterol gallstone formation in guinea pigs fed a high cholesterol diet. Int J Clin Exp Pathol. 2018;11(3):1653–9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McCabe 4th M.E., Dilly C.K. New causes for the old problem of bile reflux gastritis. Clin Gastroenterol Hepatol. 2018;16(9):1389–92. DOI: 10.1016/j.cgh.2018.02.034</mixed-citation><mixed-citation xml:lang="en">McCabe 4th M.E., Dilly C.K. New causes for the old problem of bile reflux gastritis. Clin Gastroenterol Hepatol. 2018;16(9):1389–92. DOI: 10.1016/j.cgh.2018.02.034</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yi S.-Q., Ohta T., Tsuchida A., Terayama H., Naito M., Li J., et al. Surgical anatomy of innervation of the gallbladder in humans and Suncus murinus with special reference to morphological understanding of gallstone formation after gastrectomy. World J Gastroenterol. 2007;13(14):2066–71. DOI: 10.3748/wjg.v13.i14.2066</mixed-citation><mixed-citation xml:lang="en">Yi S.-Q., Ohta T., Tsuchida A., Terayama H., Naito M., Li J., et al. Surgical anatomy of innervation of the gallbladder in humans and Suncus murinus with special reference to morphological understanding of gallstone formation after gastrectomy. World J Gastroenterol. 2007;13(14):2066–71. DOI: 10.3748/wjg.v13.i14.2066</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Павлов Ч.С., Попова И.Р., Шульпекова Ю.О. Тримебутина малеат в лечении функциональных билиарных расстройств: результаты наблюдательного исследования TRIBUNE. Медицинский совет. 2018;21:117–25. DOI: 10.21518/2079-701X-2018-21-117-125</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Pavlov Ch.S., Popova I.R., Shulpekova Yu.O. Trimebutine maleate in the treatment of functional biliary disorders: TRIBUNE study results. Meditsinsky Sovet. 2018;21:117–25. (In Russ.). DOI: 10.21518/2079-701X-2018-21-117-125</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Тропская Н.С., Попова Т.С. Механизм действия тримебутина в коррекции функциональных расстройств желудочно-кишечного тракта. Клиническая гастроэнтерология и гепатология. Русское издание. 2008;1(4):1–4.</mixed-citation><mixed-citation xml:lang="en">Tropskaya N.S., Popova T.S. Mechanism of trimebutine affect in the functional gastrointestinal disorders. Klinicheskaya gastroenterologiya i gepatologiya. Russkoe izdanie. 2008;1(4):1–4. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Holzer P. Opioids and opioid receptors in the enteric nervous system: From a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neuroscience Letters. 2004;361(1–3):192–5. DOI: 10.1016/j.neulet.2003.12.004</mixed-citation><mixed-citation xml:lang="en">Holzer P. Opioids and opioid receptors in the enteric nervous system: From a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neuroscience Letters. 2004;361(1–3):192–5. DOI: 10.1016/j.neulet.2003.12.004</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vitton V., Ezzedine S., Gonzalez J.-M., Gasmi M., Grimaud J.-C., Barthet M. Medical treatment for sphincter of Oddi dysfunction: Can it replace endoscopic sphincterotomy? World J Gastroenterol. 2012;18(14):1610–5. DOI: 10.3748/wjg.v18.i14.1610</mixed-citation><mixed-citation xml:lang="en">Vitton V., Ezzedine S., Gonzalez J.-M., Gasmi M., Grimaud J.-C., Barthet M. Medical treatment for sphincter of Oddi dysfunction: Can it replace endoscopic sphincterotomy? World J Gastroenterol. 2012;18(14):1610–5. DOI: 10.3748/wjg.v18.i14.1610</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ogawa N., Nakajima S., Tamada K., Yokoue N., Tachibana H., Okazawa M., et al. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages. Arch Biochem Biophys. 2021;711:109029. DOI: 10.1016/j.abb.2021.109029</mixed-citation><mixed-citation xml:lang="en">Ogawa N., Nakajima S., Tamada K., Yokoue N., Tachibana H., Okazawa M., et al. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages. Arch Biochem Biophys. 2021;711:109029. DOI: 10.1016/j.abb.2021.109029</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
